REVIEW article
Front. Cell Dev. Biol.
Sec. Cell Death and Survival
The Inflammatory Clock: How cGAS-STING Ticks in the Aging Ovary
Provisionally accepted- 1Jiangnan University Wuxi School of Medicine, Wuxi, China
- 2Wuxi Maternity and Child Health Care Hospital, Wuxi, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Premature ovarian insufficiency (POI) is more than a fertility issue; it's a silent epidemic of accelerated systemic aging in young women, with current treatments failing to address its root cause. For too long, the relentless decline of ovarian function has been viewed as an inevitable mystery. But what if the ovary holds an internal "inflammatory clock," ticking away with each cellular insult and dictating the pace of its own decline? Here, we spotlight a surprising culprit: the cGAS-STING signaling pathway. Far beyond its day job in antiviral defense, this pathway emerges as a master integrator of ovarian aging. We reveal how stresses like DNA damage and mitochondrial dysfunction leak genetic material into the cell's interior, where cGAS-STING sounds a relentless alarm. This alarm doesn't just trigger inflammation; it initiates a vicious, self-amplifying cycle of cellular senescence, tissue fibrosis, and follicle destruction—a cycle that may explain why ovarian aging often feels like a one-way street. Therapeutically, we move beyond mere symptom management to explore strategies for resetting this inflammatory clock. We dissect both direct "brakes"—novel small molecules that silence cGAS or STING—and upstream "shields" that protect cellular powerplants and genome integrity. Most provocatively, we introduce the concept of "signal reprogramming": not just shutting down the pathway, but cleverly rewiring its output to favor repair over destruction. By repositioning cGAS-STING from a simple sensor to the central processor of ovarian aging, this review charts a course for a new class of therapeutics aimed at preserving ovarian function, not just managing its loss. The goal is no less than transforming our approach to women's reproductive longevity.
Keywords: cGAS-STING, Inflammation, Ovarian aging, PREMATURE OVARIAN INSUFFICIENCY, therapeutic targets
Received: 19 Dec 2025; Accepted: 30 Jan 2026.
Copyright: © 2026 Ma, Chen, Yuan, Li, Luo and Gu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Yanfang Gu
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
